home / press / releases

Menu
  • Search all tables

releases: https://www.mccaskill.senate.gov/media-center/latest-headlines/claire-mccaskill-blasts-mr-wu-tang-martin-shkreli-over-drug-pricing

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url title date year month party chamber state member_name bioguide_id domain scraper source date_source text has_text collected_at updated_at
https://www.mccaskill.senate.gov/media-center/latest-headlines/claire-mccaskill-blasts-mr-wu-tang-martin-shkreli-over-drug-pricing Claire McCaskill Blasts 'Mr. Wu-Tang' Martin Shkreli Over Drug Pricing 2015-12-09 2015 2015-12 Democrat House MO Claire McCaskill M001170 www.mccaskill.senate.gov     legacy Claire McCaskill Blasts 'Mr. Wu-Tang' Martin Shkreli Over Drug Pricing Wednesday, December 9, 2015 By: Zachary Tracer During a Wednesday Senate hearing on drug prices, Missouri Senator Claire McCaskill took aimat Turing Pharmaceuticals AG founder Martin Shkreli's spending habits. I noticed in the morning paper, this is the same guy who thought it was a great idea to pay millions of dollars for the only existing album of the Wu-Tang Clan, McCaskill said at the hearing. Shkreli earlier this yearpaid $2 millionto buy the sole copy of an album by the legendary rap group, Bloomberg Businessweek reported Wednesday. McCaskill, who referred to Shkreli as Mr. Wu-Tang, made her comments at a hearing of the Senate Special Committee on Aging. While Shkreli wasn't in attendance, McCaskill and panel witnesses criticized both him and Turing Pharmaceuticals AG. In August, Turing acquired the rights to a decades-old medicine that's used to treat infections that can happen in HIV and cancer patients, and babies with vulnerable immune systems. The company immediately raised the price to$750 a pill, from $13.50, prompting outrage. Print Email Tweet 1 2026-03-30T12:14:52Z 2026-03-30T12:14:52Z
Powered by Datasette · Queries took 1.985ms · Data license: MIT · Data source: dwillis/congress-press